A patient with diabetes presents with an HbA1c level of 8.4%, elevated LDL cholesterol, microalbuminuria, and signs of diabetic retinopathy and neuropathy. Which intervention should the nurse prioritize to address the patient's current condition and prevent further complications?

A) Initiate a referral for a renal dietitian for dietary management

B) Educate the patient on increasing physical activity to improve insulin sensitivity

D) Schedule an immediate ophthalmology follow-up to monitor retinopathy progression

A patient with type 2 diabetes presents with an HbA1c level of 8.4%, elevated LDL cholesterol, and signs of early diabetic nephropathy. Which of the following interventions should the nurse prioritize to address the multiple complications noted in this patient?

B) Recommend the addition of a GLP-1 receptor agonist to the treatment plan to improve glycemic control.

A) Educate the patient on the importance of daily foot care to prevent diabetic foot ulcers.

B) Recommend the addition of a GLP-1 receptor agonist to the treatment plan to improve glycemic control.

C) Suggest increasing the dose of atorvastatin to better manage the patient's lipid levels.

D) Initiate a referral to a dietitian for nutritional counseling to address insulin resistance.

A patient with type 2 diabetes and hypertension reports improved energy levels and a decrease in numbness and tingling in his feet following dietary changes and increased physical activity. Despite improvements, his LDL cholesterol remains elevated at 138 mg/dL, and triglycerides are at 210 mg/dL. Which nursing intervention should be prioritized to address the patient's lipid profile?

A) Encourage the patient to increase the intake of omega-3 fatty acids.

B) Reassess the patient's adherence to the antihypertensive medication regimen.

C) Recommend the patient reduce sodium intake to further lower blood pressure.

D) Suggest the patient incorporate more plant-based proteins into his diet.

A patient with a history of type 2 diabetes and hypertension shows improved HbA1c levels and blood pressure control after revising their management plan. However, their lipid profile remains suboptimal, and renal function is stable but requires monitoring. Which nursing intervention should be prioritized to address the patient's current health status?

B) Reinforce dietary modifications to include foods that specifically lower LDL cholesterol.

A) Increase the frequency of blood pressure monitoring to ensure continued control.

B) Reinforce dietary modifications to include foods that specifically lower LDL cholesterol.

C) Educate the patient on the importance of daily foot care to prevent complications.

D) Schedule a consultation with a nephrologist to evaluate renal function management.

A patient with a history of diabetes mellitus presents with increased fatigue, swelling in the lower extremities, and occasional shortness of breath on exertion. Laboratory findings indicate a decline in renal function and elevated HbA1c. Which nursing intervention is most appropriate to address the patient's current symptoms and prevent further complications?

B) Educate the patient on the importance of adhering to a low-sodium diet to reduce fluid retention.

A) Encourage the patient to increase fluid intake to improve renal perfusion.

B) Educate the patient on the importance of adhering to a low-sodium diet to reduce fluid retention.

C) Recommend increased physical activity to improve cardiovascular health and reduce edema.

D) Advise the patient to reduce protein intake to prevent further decline in kidney function.

A patient with a history of diabetes and recently increased serum creatinine presents with new onset pitting edema and exertional dyspnea. Which nursing intervention is most appropriate to address the patient's symptoms and prevent further complications?

C) Monitor daily weights and educate the patient on the signs of worsening heart failure.

A) Educate the patient on reducing daily fluid intake to manage fluid retention.

B) Instruct the patient on the importance of regular physical activity to improve cardiovascular health.

C) Monitor daily weights and educate the patient on the signs of worsening heart failure.

D) Encourage a high-protein diet to improve renal function and reduce creatinine levels.

A patient with diabetic nephropathy and early heart failure with preserved ejection fraction (HFpEF) has been started on an ACE inhibitor. Which nursing intervention is most important to implement to ensure patient safety after initiating this medication?

B) Assess for signs of angioedema and monitor blood pressure.

A) Monitor the patient's blood glucose levels closely.

B) Assess for signs of angioedema and monitor blood pressure.

C) Encourage the patient to increase dietary potassium intake.

D) Schedule regular weight-bearing exercise sessions.

A patient with diabetic nephropathy and heart failure with preserved ejection fraction (HFpEF) has been started on an ACE inhibitor to address hypertension and renal protection. During a follow-up visit, the patient reports waking up multiple times at night to urinate. Which nursing intervention is most appropriate to address the patient's symptoms of nocturia and optimize his treatment plan?

A) Educate the patient on taking the diuretic earlier in the day.

B) Encourage increased fluid intake in the evening to maintain hydration.

C) Advise the patient to limit physical activity late in the day.

D) Suggest the patient use compression stockings to reduce nocturnal fluid shift.

A patient with heart failure is on an ACE inhibitor and presents with occasional dizziness upon standing, improved blood pressure, and a potassium level at the upper limit of normal. What is the most appropriate nursing action to address the patient's dizziness?

A) Educate the patient on rising slowly from a sitting or lying position.

B) Increase the dosage of the ACE inhibitor to further manage blood pressure.

C) Advise the patient to increase fluid intake to counteract dizziness.

D) Suggest that the patient discontinue the ACE inhibitor immediately.

A patient with heart failure is on a new treatment regimen including an ACE inhibitor. He reports occasional dizziness upon standing, improved nocturia, and has an elevated albumin-to-creatinine ratio. Laboratory results show a potassium level at the upper limit of normal. What is the most appropriate nursing intervention to address the patient's risk of orthostatic hypotension?

B) Advise the patient to stand up slowly and dangle legs at the bedside before standing

A) Encourage the patient to increase fluid intake to maintain blood pressure

B) Advise the patient to stand up slowly and dangle legs at the bedside before standing

C) Suggest the patient reduce sodium intake further to improve fluid balance

D) Instruct the patient to take an additional diuretic dose if dizziness occurs

diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance in muscle and adipose tissues reduces glucose uptake, leading to hyperglycemia. This resistance is often due to obesity-related inflammation and genetic factors affecting insulin receptor signaling.

• Secondary mechanism: Pancreatic beta-cell dysfunction results in inadequate insulin production and secretion. Over time, chronic exposure to high glucose levels (glucotoxicity) and fatty acids (lipotoxicity) further impair beta-cell function and mass.

• Key complication: Persistent hyperglycemia causes damage to blood vessels, leading to microvascular complications like retinopathy, nephropathy, and neuropathy, as well as macrovascular issues such as cardiovascular disease, which are critical in nursing considerations for patient care.

Patient Profile

Demographics:

52-year-old male, office manager

History:

• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent numbness and tingling in feet

• Key symptoms: Increased thirst, frequent urination, blurred vision, fatigue, slow-healing sores

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 210 mg/dL

Section 1

New Diagnostic Results:

The patient underwent a series of diagnostic tests to further assess the extent of his diabetic complications. The laboratory results revealed an HbA1c level of 8.4%, indicating poor long-term glycemic control. A lipid panel showed elevated LDL cholesterol at 145 mg/dL and triglycerides at 220 mg/dL, suggesting that the current statin therapy may not be adequately controlling his lipid levels. Renal function tests highlighted a slightly elevated creatinine level of 1.4 mg/dL and a decreased estimated glomerular filtration rate (eGFR) of 58 mL/min/1.73 m², raising concerns about early diabetic nephropathy. Additionally, a microalbuminuria test confirmed the presence of albuminuria, with an albumin-to-creatinine ratio of 45 mg/g, further indicating compromised kidney function.

Ophthalmological examination revealed the presence of moderate non-proliferative diabetic retinopathy, characterized by microaneurysms and occasional retinal hemorrhages. Sensory testing with a monofilament indicated decreased sensation in the feet, confirming diabetic peripheral neuropathy. These findings correlate with the patient's symptoms of numbness and tingling and underscore the progressive nature of his diabetes-related complications.

Given these results, the clinical team discussed the need for a more intensive management plan. This includes considering the addition of a GLP-1 receptor agonist or SGLT2 inhibitor to better control blood glucose levels, reevaluating antihypertensive therapy to achieve target blood pressure, and potentially increasing the dose of atorvastatin or switching to a more potent statin. The team also emphasized the importance of lifestyle modifications, including dietary changes and increased physical activity, to address the underlying insulin resistance and improve overall cardiovascular health. These steps are critical in preventing further progression of microvascular and macrovascular complications, and the patient was scheduled for follow-up appointments to monitor the effectiveness of the revised treatment strategy.

Section 2

Response to Interventions

Following the implementation of the revised management plan, the patient returned for a follow-up appointment six weeks later. During this visit, initial observations indicated some positive changes. The patient reported a slight improvement in energy levels and a modest reduction in the numbness and tingling in his feet. He also mentioned adhering more closely to dietary recommendations, incorporating more fiber and reducing carbohydrate intake, and had begun walking for 30 minutes most days of the week as advised by the clinical team.

Vital signs revealed a blood pressure of 132/78 mmHg, demonstrating better control compared to previous readings. This improvement was attributed to the adjusted antihypertensive therapy. The laboratory results were also encouraging; the patient's HbA1c had decreased to 7.9%, suggesting a trend towards improved glycemic control, potentially due to the addition of the SGLT2 inhibitor. However, the lipid profile remained suboptimal, with LDL cholesterol at 138 mg/dL and triglycerides at 210 mg/dL, indicating that further adjustments to the lipid-lowering regimen might be necessary.

Despite these improvements, the patient's eGFR remained stable at 58 mL/min/1.73 m², and the albumin-to-creatinine ratio was slightly reduced to 42 mg/g, indicating that renal function had not worsened but continued to require close monitoring. Given these findings, the clinical team emphasized the need for ongoing adherence to lifestyle changes and medication adjustments. The patient was advised to continue monitoring his blood glucose levels at home and to report any significant changes in symptoms promptly. The plan included a follow-up appointment in three months to reassess the patient's progress and make further modifications to the treatment strategy as needed.

Section 3

Three months later, the patient returned for his follow-up appointment. During this visit, he expressed concern about new symptoms, including increased fatigue and swelling in his lower extremities, particularly around the ankles. These symptoms had gradually developed over the past several weeks. Upon physical examination, pitting edema was observed in both legs, raising concerns about fluid retention. The patient also reported occasional shortness of breath during exertion, which he had not experienced before.

Vital signs showed a blood pressure of 138/86 mmHg, slightly elevated from the previous visit, and a heart rate of 88 beats per minute. Laboratory tests revealed an increase in serum creatinine to 1.8 mg/dL, with a corresponding decrease in eGFR to 48 mL/min/1.73 m², indicating a decline in renal function. The albumin-to-creatinine ratio had increased to 55 mg/g. Additionally, the patient's HbA1c had slightly increased to 8.2%, suggesting a potential lapse in glycemic control. The lipid profile remained unchanged, with LDL cholesterol at 136 mg/dL and triglycerides at 215 mg/dL.

These findings prompted the clinical team to consider the possibility of diabetic nephropathy progression and possibly congestive heart failure, given the symptoms of fluid retention and exertional dyspnea. The team decided to adjust the patient's diuretic therapy to address the edema and closely monitor renal function. Additionally, they reinforced the importance of strict adherence to dietary and medication regimens to manage his diabetes and cardiovascular risks. The patient was scheduled for further diagnostic imaging and cardiology consultation to evaluate the extent of cardiac involvement and to tailor the treatment plan accordingly.

Section 4

Three weeks following the adjustment of his diuretic therapy, the patient returned for a follow-up appointment. He reported a modest improvement in his lower extremity swelling, though he continued to experience exertional dyspnea. A physical examination revealed a reduction in pitting edema, though mild swelling persisted. His blood pressure had shown a slight improvement, now reading 134/84 mmHg, and his heart rate remained stable at 86 beats per minute. However, the patient disclosed experiencing nocturia, waking two to three times a night to urinate, which had disrupted his sleep.

Laboratory tests indicated a further increase in serum creatinine to 2.0 mg/dL, with eGFR decreasing to 42 mL/min/1.73 m², suggesting ongoing renal impairment. The albumin-to-creatinine ratio had worsened to 68 mg/g, reinforcing concerns about diabetic nephropathy progression. An echocardiogram, obtained since the last visit, showed mild left ventricular hypertrophy and an ejection fraction of 55%, consistent with early signs of heart failure with preserved ejection fraction (HFpEF). These findings prompted the clinical team to reconsider the current management strategy, focusing on optimizing heart failure treatment while continuing to address renal function decline.

Given the patient's complex presentation, the team decided to introduce an ACE inhibitor to address both hypertension and renal protection, considering the potential benefits for heart failure management. They also emphasized the need for dietary sodium restriction and fluid management. With these adjustments, the team anticipated a gradual improvement in symptoms, closely monitoring for any signs of electrolyte imbalance or further renal deterioration. The patient was scheduled for weekly follow-up appointments to assess response to interventions and to ensure timely adjustments to his treatment plan.

Section 5

Two weeks into the new treatment regimen, the patient returned for a follow-up appointment, reporting some positive changes and new concerns. His nocturia had slightly improved, now only waking him once per night, suggesting some stabilization in fluid balance. However, he began experiencing occasional dizziness upon standing, which could indicate orthostatic hypotension, a potential side effect of the ACE inhibitor. Despite these concerns, his blood pressure readings had improved further to 128/80 mmHg, reflecting better control.

New laboratory results showed mixed progress. Serum creatinine levels had stabilized at 1.8 mg/dL, and eGFR had slightly improved to 45 mL/min/1.73 m², indicating a modest improvement in renal function. However, the albumin-to-creatinine ratio remained elevated at 65 mg/g, still highlighting ongoing renal stress. Electrolytes were closely monitored, revealing a potassium level at the upper limit of normal at 5.0 mEq/L, necessitating vigilance for hyperkalemia, a known risk with ACE inhibitors.

Clinically, the patient appeared less dyspneic, and his exertional tolerance had improved slightly, suggesting some benefit to cardiac function. However, the persistence of mild lower extremity edema indicated that further optimization of heart failure management might be necessary. The team decided to adjust the diuretic dosage cautiously, balancing fluid status with the risk of exacerbating renal function. The patient was advised to continue dietary sodium restriction and to report any new symptoms promptly. These steps aimed to fine-tune the therapeutic approach, ensuring that improvements in blood pressure and renal function translated into better overall outcomes. The team planned to reassess in one week, prepared to make further modifications based on the evolving clinical picture.